This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Mar;42(1):133-6.

doi: 10.1007/s11255-009-9649-3. Epub 2009 Oct 14.

Jupiter or Aurora? Micro-inflammation and dyslipidaemia: twin targets for statin therapy in CKD

David Goldsmith, Adrian C Covic

PMID: 19826907
DOI: 10.1007/s11255-009-9649-3

Editorial

Jupiter or Aurora? Micro-inflammation and dyslipidaemia: twin targets for statin therapy in CKD

David Goldsmith et al. Int Urol Nephrol. 2010 Mar.

. 2010 Mar;42(1):133-6.

doi: 10.1007/s11255-009-9649-3. Epub 2009 Oct 14.

Authors

David Goldsmith, Adrian C Covic

PMID: 19826907
DOI: 10.1007/s11255-009-9649-3

No abstract available

PubMed Disclaimer

Similar articles

Chronic kidney disease and statins: improving cardiovascular outcomes.
Walker DB, Walker TJ, Jacobson TA. Walker DB, et al. Curr Atheroscler Rep. 2009 Jul;11(4):301-8. doi: 10.1007/s11883-009-0046-2. Curr Atheroscler Rep. 2009. PMID: 19500494 Review.
Cardiovascular disease in patients with renal disease: the role of statins.
Fellström B, Holdaas H, Jardine AG, Svensson MK, Gottlow M, Schmieder RE, Zannad F; AURORA Study Group. Fellström B, et al. Curr Med Res Opin. 2009 Jan;25(1):271-85. doi: 10.1185/03007990802622064. Curr Med Res Opin. 2009. PMID: 19210158 Review.
Lipoprotein metabolism and lipid management in chronic kidney disease.
Kwan BC, Kronenberg F, Beddhu S, Cheung AK. Kwan BC, et al. J Am Soc Nephrol. 2007 Apr;18(4):1246-61. doi: 10.1681/ASN.2006091006. Epub 2007 Mar 14. J Am Soc Nephrol. 2007. PMID: 17360943 Review. No abstract available.
Dyslipidemia in children with CKD: should we treat with statins?
Tullus K. Tullus K. Pediatr Nephrol. 2012 Mar;27(3):357-62. doi: 10.1007/s00467-011-1872-3. Epub 2011 Apr 13. Pediatr Nephrol. 2012. PMID: 21487766 Review.
Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.
Kanbay M, Turgut F, Covic A, Goldsmith D. Kanbay M, et al. J Nephrol. 2009 Sep-Oct;22(5):598-609. J Nephrol. 2009. PMID: 19809992 Review.

See all similar articles

Cited by

Twenty four-hour ambulatory blood pressure monitoring and lipid levels before, 3, 6 and 12 months after the onset of hemodialysis in chronic kidney disease patients: a pilot study.
Vagiona A, Koupidis S, Passadakis P, Thodis E, Vargemezis V. Vagiona A, et al. Hippokratia. 2012 Apr;16(2):154-8. Hippokratia. 2012. PMID: 23935271 Free PMC article.
Statins for renal patients: a fiddler on the roof?
Guedes AM, Neves PL. Guedes AM, et al. Int J Nephrol. 2012;2012:806872. doi: 10.1155/2012/806872. Epub 2012 Oct 22. Int J Nephrol. 2012. PMID: 23133753 Free PMC article.
Inflammatory Stress Exacerbated Mesangial Foam Cell Formation and Renal Injury via Disrupting Cellular Cholesterol Homeostasis.
Zhong S, Zhao L, Li Q, Yang P, Varghese Z, Moorhead JF, Chen Y, Ruan XZ. Zhong S, et al. Inflammation. 2015;38(3):959-71. doi: 10.1007/s10753-014-0058-0. Inflammation. 2015. PMID: 25387652

References

1. Kidney Int. 2008 Dec;74(11):1461-7 - PubMed
1. N Engl J Med. 2005 Jul 21;353(3):238-48 - PubMed
1. N Engl J Med. 2009 Apr 2;360(14):1395-407 - PubMed
1. Am J Kidney Dis. 2006 Mar;47(3):385-95 - PubMed
1. N Engl J Med. 2008 Nov 20;359(21):2195-207 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Health Information